News search

The new equipment will facilitate work with mouse embryonic stem cells and human induced pluripotent stem cells (hiPSCs), fundamental tools for developing experimental models of cardiovascular disease

A new analysis of the DapaTAVI trial, published in the European Journal of Heart Failure, confirms that dapagliflozin improves outcomes after TAVI regardless of cardiac function.

The findings suggest that a risk-based personalized approach may be more efficient than applying intensive surveillance protocols uniformly to all patients. 

The study reveals that the early heart is shaped by distinct but closely coordinated patterns of tissue deformation 

The aim of the Acércate Programme is to train the brightest young people from a very early age in order to build a pool of outstanding researchers in the field of cardiovascular research 

Hypertrophic cardiomyopathy is the most common inherited heart disease and the leading cause of sudden cardiac death in young people and athletes

The meeting forms part of European awareness-raising activities around the European Commission’s new strategy to strengthen prevention, early detection, and management of cardiovascular disease